Psychiatry and Neurology, Neurology · Memphis, TN
NPI
1407813439
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5050 Poplar Ave Ste 511
Memphis, TN, 38157
Phone (901) 443-9170
Groups this clinician bills Medicare through
Medicare paid, 2024
$201K
14,616 services
Medicare patients, 2024
499
Average age 74
Drug cost, 2024
$4.7M
6,033 prescriptions
Company payments, 2025
$44K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark S Ledoux was code J0588 (injection, incobotulinumtoxin a, 1 unit), 10,088 times for 38 patients. In total Mark S Ledoux billed 14,616 services in 23 codes, and Medicare paid $201K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 10,088 | 38 | $3.98 | $40K |
| 99214 Office E&M - Established | Office | 1,053 | 446 | $90.49 | $95K |
| 95874 Musculoskeletal | Office | 112 | 45 | $58.12 | $6,509 |
| 99215 Office E&M - Established | Office | 83 | 71 | $122.56 | $10K |
| 64616 Musculoskeletal | Office | 71 | 27 | $136.50 | $9,692 |
| 64612 Musculoskeletal | Office | 52 | 19 | $148.34 | $7,714 |
| 99204 Office E&M - New | Office | 48 | 48 | $121.37 | $5,826 |
| 99213 Office E&M - Established | Office | 29 | 16 | $64.83 | $1,880 |
| 99205 Office E&M - New | Office | 25 | 25 | $167.61 | $4,190 |
| 95983 Electrical Nerve Conductivity | Office | 15 | 12 | $34.19 | $513 |
By year: 2022 $216K for 19,761 services; 2023 $184K for 17,558 services; 2024 $201K for 14,616 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark S Ledoux prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 863 prescriptions and refills. In total Mark S Ledoux wrote 6,033 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 863 | 1,901 | 243 | $28K |
| Rasagiline Mesylate Generic | 513 | 1,204 | 139 | $76K |
| Rytary Carbidopa/Levodopa | 462 | 725 | 82 | $646K |
| Donepezil Hcl Generic | 363 | 756 | 99 | $4,555 |
| Clonazepam Generic | 321 | 321 | 53 | $1,256 |
| Austedo Xr Deutetrabenazine | 268 | 268 | 20 | $2.3M |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 254 | 579 | 68 | $6,672 |
| Quetiapine Fumarate Generic | 200 | 379 | 51 | $1,932 |
| Gabapentin Generic | 183 | 202 | 30 | $1,301 |
| Escitalopram Oxalate Generic | 159 | 385 | 48 | $2,178 |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 142 | 212 | 32 | $33K |
| Entacapone Generic | 96 | 162 | 24 | $22K |
| Potassium Chloride Generic | 95 | 171 | 23 | $1,243 |
| Amantadine Amantadine Hcl | 94 | 245 | 28 | $7,592 |
| Primidone Generic | 89 | 212 | 24 | $2,848 |
Brand drugs: 1,379 claims; generic drugs: 4,654 claims; opioid claims: 71.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark S Ledoux $44K ($44K in general payments such as food, travel and fees) from 7 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $23K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.